PublizoomAward notice Supplies
Suministro de los productos farmacéuticos Levatinib, Pemigarinib, Ruxolitinib y Evinacumab para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria
Notice published in Spanish. The AI analysis summarises it for you in your language.
- Public buyer
- Consejería de Sanidad del Gobierno de Canarias
Las Palmas de Gran Canaria - Place of performance
- Las Palmas de Gran Canaria
- Estimated value
- €840,500 excl. VAT
- Amount awarded
- €700,417 excl. VAT
- Bids received
- 1
- Procedure
- Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part. - Publication
- 2 September 2026
- Notice language
- Spanish
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Suministro de los productos farmacéuticos Levatinib, Pemigarinib, Ruxolitinib y Evinacumab para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria.
Awarded to
2 lots
- Pemigarinib
- Ruxolitinib 15mg/g
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €202,502
- Median
- €425,325
- A quarter above
- €1,046,198
Amounts awarded (excl. VAT) over the last 3 years for 163 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 605241-2026.